Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cilloni

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Leukemia|March 23, 2007
CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536A Morotti, G Parvis, D Cilloni, et al.
Leukemia|November 5, 2005
The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistanceD Cilloni, F Messa, F Arruga, et al.
American Journal of Hematology|September 9, 2006
NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell lineA Morotti, D Cilloni, M Pautasso, et al.
Leukemia|November 7, 2013
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidineA Valencia, E Masala, A Rossi, et al.
Leukemia|April 11, 2008
Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutationsD Cilloni, F Messa, V Rosso, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Detection of BCR/ABL rearrangements in adult acute lymphoblastic leukemia using a highly sensitive interphase fluorescence in situ hybridization method (D-FISH)M Mancini, M Nanni, P Sirleto, et al.
Leukemia|January 15, 2010
WITHDRAWN: Proteinase 3 (PR3) gene is highly expressed in CBF leukemias and codes for a protein with abnormal nuclear localization that confers drug sensitivityD Cilloni, S Carturan, C Maffè, et al.
Leukemia|November 7, 2008
The molecular anatomy of the FIP1L1-PDGFRA fusion geneC Walz, J Score, J Mix, et al.
Leukemia|June 14, 2017
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemiaV Santini, B Allione, G Zini, et al.
Leukemia|May 18, 2007
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemiaD Cilloni, F Messa, G Martinelli, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Leukemia|March 23, 2007
CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536A Morotti, G Parvis, D Cilloni, et al.
Leukemia|November 5, 2005
The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistanceD Cilloni, F Messa, F Arruga, et al.
American Journal of Hematology|September 9, 2006
NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell lineA Morotti, D Cilloni, M Pautasso, et al.
Leukemia|November 7, 2013
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidineA Valencia, E Masala, A Rossi, et al.
Leukemia|April 11, 2008
Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutationsD Cilloni, F Messa, V Rosso, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Detection of BCR/ABL rearrangements in adult acute lymphoblastic leukemia using a highly sensitive interphase fluorescence in situ hybridization method (D-FISH)M Mancini, M Nanni, P Sirleto, et al.
Leukemia|January 15, 2010
WITHDRAWN: Proteinase 3 (PR3) gene is highly expressed in CBF leukemias and codes for a protein with abnormal nuclear localization that confers drug sensitivityD Cilloni, S Carturan, C Maffè, et al.
Leukemia|November 7, 2008
The molecular anatomy of the FIP1L1-PDGFRA fusion geneC Walz, J Score, J Mix, et al.
Leukemia|June 14, 2017
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemiaV Santini, B Allione, G Zini, et al.
Leukemia|May 18, 2007
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemiaD Cilloni, F Messa, G Martinelli, et al.
Pageof 4